Literature DB >> 6218459

Classification of chronic blepharitis.

J P McCulley, J M Dougherty, D G Deneau.   

Abstract

Since last thoroughly evaluated over three decades ago, the clinical spectrum of chronic blepharitis has changed. The relative prevalence of Staphylococcus aureus alone or in combination with seborrheic blepharitis has decreased. The relative prevalence has increased of seborrheic blepharitis with or without associated excess meibomian secretions (meibomian seborrhea) or inflammation (meibomitis). Primary meibomitis appears not to be a primarily infectious entity but to represent a facet of generalized sebaceous gland dysfunction and to be found in association with seborrheic dermatitis or acne rosacea. The keratoconjunctivitis found in association with primary meibomitis may be contributed to by the production of bacterial lypolytic exoenzymes that split neutral lipids, resulting in an increased level of free fatty acids in the tears. A frequent finding of keratoconjunctivitis sicca in this patient population, especially the S. aureus group (50%), is of note. Of particular importance is that these entities be recognized as chronic diseases requiring control and ones for which there is no "cure."

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6218459     DOI: 10.1016/s0161-6420(82)34669-2

Source DB:  PubMed          Journal:  Ophthalmology        ISSN: 0161-6420            Impact factor:   12.079


  55 in total

1.  Ophthaproblem. Blepharitis.

Authors:  J Cheung; S Sharma
Journal:  Can Fam Physician       Date:  2000-12       Impact factor: 3.275

Review 2.  Interventions for chronic blepharitis.

Authors:  Kristina Lindsley; Sueko Matsumura; Elham Hatef; Esen K Akpek
Journal:  Cochrane Database Syst Rev       Date:  2012-05-16

3.  The evaluation of the treatment response in obstructive meibomian gland disease by in vivo laser confocal microscopy.

Authors:  Yukihiro Matsumoto; Yuta Shigeno; Enrique Adan Sato; Osama M A Ibrahim; Megumi Saiki; Kazuno Negishi; Yoko Ogawa; Murat Dogru; Kazuo Tsubota
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2008-12-20       Impact factor: 3.117

4.  Meibography: A review of techniques and technologies.

Authors:  Ryan J Wise; Rachel K Sobel; Richard C Allen
Journal:  Saudi J Ophthalmol       Date:  2012-10

Review 5.  The international workshop on meibomian gland dysfunction: report of the diagnosis subcommittee.

Authors:  Alan Tomlinson; Anthony J Bron; Donald R Korb; Shiro Amano; Jerry R Paugh; E Ian Pearce; Richard Yee; Norihiko Yokoi; Reiko Arita; Murat Dogru
Journal:  Invest Ophthalmol Vis Sci       Date:  2011-03-30       Impact factor: 4.799

Review 6.  The international workshop on meibomian gland dysfunction: report of the definition and classification subcommittee.

Authors:  J Daniel Nelson; Jun Shimazaki; Jose M Benitez-del-Castillo; Jennifer P Craig; James P McCulley; Seika Den; Gary N Foulks
Journal:  Invest Ophthalmol Vis Sci       Date:  2011-03-30       Impact factor: 4.799

Review 7.  [Chronic blepharitis. Pathogenesis, clinical features, and therapy].

Authors:  C Auw-Haedrich; T Reinhard
Journal:  Ophthalmologe       Date:  2007-09       Impact factor: 1.059

Review 8.  [Blepharitis].

Authors:  T Kaercher; H Brewitt
Journal:  Ophthalmologe       Date:  2004-11       Impact factor: 1.059

9.  Regulation of T-cell chemotaxis by programmed death-ligand 1 (PD-L1) in dry eye-associated corneal inflammation.

Authors:  Jaafar El Annan; Sunali Goyal; Qiang Zhang; Gordon J Freeman; Arlene H Sharpe; Reza Dana
Journal:  Invest Ophthalmol Vis Sci       Date:  2009-12-17       Impact factor: 4.799

10.  Efficacy and safety of mercuric oxide in the treatment of bacterial blepharitis.

Authors:  R A Hyndiuk; E M Burd; A Hartz
Journal:  Antimicrob Agents Chemother       Date:  1990-04       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.